- CytRx Corporation (OTCQB:CYTR) said on Wednesday it had been awarded a patent by the European Patent Office that covers the incorporation of the LADR backbone in a variety of drug compounds.
- The LADR backbone is attached to active pharmaceutical agents in order to target the agents to the diseased tissue.
- The company also received a U.S. patent for its LADR platform.
- CytRx has also pursued patent protection covering certain specific drugs that incorporate the LADR backbone.
European patent office awards CytRx patent for LADR platform
Recommended For You
More Trending News
About LADX Stock
Related Stocks
| Symbol | Last Price | % Chg |
|---|---|---|
| LADX | - | - |
| LadRx Corporation | ||